UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006809 |
|---|---|
| Receipt number | R000007916 |
| Scientific Title | Phase II Study of Paclitaxel and Carboplatin plus Bevacizumab in StageIIIA-N2, IIIB, IV patients with Nonsquamous Non-Small-Cell Lung Cancer |
| Date of disclosure of the study information | 2011/12/01 |
| Last modified on | 2020/06/07 09:25:40 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/12/01 12:12:12 | ||
| 2 | Update | 2011/12/13 15:57:22 | Primary outcomes |
|
| 3 | Update | 2011/12/13 16:06:30 | Last name of lead principal investigator Last name of lead principal investigator Institute Institute Co-sponsor Co-sponsor |
|
| 4 | Update | 2011/12/14 13:39:35 | Institutions |
|
| 5 | Update | 2011/12/16 13:35:10 | Organization Organization Category of Funding Organization |
|
| 6 | Update | 2012/04/27 07:59:17 | Recruitment status Anticipated trial start date |
|
| 7 | Update | 2012/06/05 14:02:03 | Email1 |
|
| 8 | Update | 2014/07/10 16:28:40 | Email |
|
| 9 | Update | 2014/12/01 23:00:32 | Key inclusion criteria |
|
| 10 | Update | 2020/06/07 09:15:25 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Institute Organization Organization Organization Organization Address Address Tel |
|
| 11 | Update | 2020/06/07 09:25:40 | Recruitment status Date of IRB Last follow-up date |
